Membranous nephropathy: Quo vadis?

被引：25

作者：

Cattran, DC ^{[1
]}

机构：

[1] Toronto Gen Hosp, Univ Hlth Network, Toronto, ON M5G 1L7, Canada

来源：

KIDNEY INTERNATIONAL | 2002年 / 61卷 / 01期

关键词：

glomerulonephritis; end-stage renal disease; proteinuria; creatinine levels;

D O I：

10.1046/j.1523-1755.2002.00125.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：349 / 350

页数：2

共 13 条

[1] Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].

Brenner, BM ;

Cooper, ME ;

de Zeeuw, D ;

Keane, WF ;

Mitch, WE ;

Parving, HH ;

Remuzzi, G ;

Snapinn, SM ;

Zhang, ZX ;

Shahinfar, S .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869

[2] A CONTROLLED TRIAL OF CYCLOSPORINE IN PATIENTS WITH PROGRESSIVE MEMBRANOUS NEPHROPATHY [J].

CATTRAN, DC ;

GREENWOOD, C ;

RITCHIE, S ;

BERNSTEIN, K ;

CHURCHILL, DN ;

CLARK, WF ;

MORRIN, PA ;

LAVOIE, S .

KIDNEY INTERNATIONAL, 1995, 47 (04) :1130-1135

[3] Validation of a predictive model of idiopathic membranous nephropathy: Its clinical and research implications [J].

Cattran, DC ;

Pei, Y ;

Greenwood, CMT ;

Ponticelli, C ;

Passerini, P ;

Honkanen, E .

KIDNEY INTERNATIONAL, 1997, 51 (03) :901-907

[4] A RANDOMIZED CONTROLLED TRIAL OF PREDNISONE IN PATIENTS WITH IDIOPATHIC MEMBRANOUS NEPHROPATHY [J].

CATTRAN, DC ;

DELMORE, T ;

ROSCOE, J ;

COLE, E ;

CARDELLA, C ;

CHARRON, R ;

RITCHIE, S .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (04) :210-215

[5]

COGGINS CH, 1979, NEW ENGL J MED, V301, P1301

[6] TREATMENT OF PROGRESSIVE MEMBRANOUS GLOMERULOPATHY - A RANDOMIZED TRIAL COMPARING CYCLOPHOSPHAMIDE AND CORTICOSTEROIDS WITH CORTICOSTEROIDS ALONE [J].

FALK, RJ ;

HOGAN, SL ;

MULLER, KE ;

JENNETTE, JC .

ANNALS OF INTERNAL MEDICINE, 1992, 116 (06) :438-445

[7] Changing etiologies of unexplained adult nephrotic syndrome: A comparison of renal biopsy findings from 1976-1979 and 1995-1997 [J].

Haas, M ;

Meehan, SM ;

Karrison, TG ;

Spargo, BH .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 30 (05) :621-631

[8] Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes [J].

Lewis, EJ ;

Hunsicker, LG ;

Clarke, WR ;

Berl, T ;

Pohl, MA ;

Lewis, JB ;

Ritz, E ;

Atkins, RC ;

Rohde, R ;

Raz, I .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :851-860

[9]

*NIH NAT I DIAB DI, 1999, US REN DAT SYST USRD

[10] PREDICTING CHRONIC RENAL-INSUFFICIENCY IN IDIOPATHIC MEMBRANOUS GLOMERULONEPHRITIS [J].

PEI, Y ;

CATTRAN, D ;

GREENWOOD, C .

KIDNEY INTERNATIONAL, 1992, 42 (04) :960-966

← 1 2 →